Nanotechnology Based Approaches for Tuberculosis Treatment
- 1st Edition - June 11, 2020
- Editor: Prashant Kesharwani
- Language: English
- Paperback ISBN:9 7 8 - 0 - 1 2 - 8 1 9 8 1 1 - 7
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 2 2 6 1 1 - 7
Nanotechnology Based Approaches for Tuberculosis Treatment discusses multiple nanotechnology-based approaches that may help overcome persisting limitations of conventio… Read more
Nanotechnology Based Approaches for Tuberculosis Treatment discusses multiple nanotechnology-based approaches that may help overcome persisting limitations of conventional and traditional treatments. The book summarizes the types of nano drugs, their synthesis, formulation, characterization and applications, along with the most important administration routes. It also explores recent advances and achievements regarding therapeutic efficacy and provides possible future applications in this field. It will be a useful resource for investigators, pharmaceutical researchers, innovators and scientists working on technology advancements in the areas of targeted therapies, nano scale imaging systems, and diagnostic modalities in tuberculosis.
- Addresses the gap between nanomedicine late discovery and early development of tuberculosis therapeutics
- Explores tuberculosis nanomedicine standardization and characterization with newly developed treatment, diagnostic and treatment monitoring modalities
- Covers the field thoroughly, from the pathogenesis of tuberculosis and multi-drug resistant mycobacterium tuberculosis, to treatment approaches using nanotechnology and different nanocarriers
Researchers, early-career investigators, and graduate students working in the pharmaceutical industries, nanomedicine, or infectious diseases
1. Pathogenesis, biology, and immunology of tuberculosisRAVI BANDARU, DEVIPRASAD SAHOO, RAMAKANTA NAIK, PRASHANT KESHARWANI AND RAMBABU DANDELA2. Tuberculosis: introduction, drug regimens, and multidrug-resistanceSIMA SINGH, NEELAM DHANKAR, ASHISH KUMAR GARG AND PRASHANT KESHARWANI3. Nanotechnology as a potential tool against drug- and multidrug-resistant tuberculosis DAMIÁN EDUARDO PÉREZ-MARTÍNEZ AND ROBERTO ZENTENO-CUEVAS4. Translational research for therapy against tuberculosis YOLANDA GONZALEZ, SILVIA GUZMÁN-BELTRÁN, LAURA E. CARRETO-BINAGHI AND ESMERALDA JUÁREZ5. Vaccine delivery systems against tuberculosis RUPAL OJHA, RAJAN KUMAR PANDEY AND VIJAY KUMAR PRAJAPATI6. Inhalable polymeric dry powders for antituberculosis drug delivery SUNEERA ADLAKHA, KALPESH VAGHASIYA, ANKUR SHARMA, EUPA RAY AND RAHUL KUMAR VERMA7. Liposomes-and niosomes-based drug delivery systems for tuberculosis treatmentALI IBRAHIM BEKRAKI8. Polymer-based nanoparticles as delivery systems for treatment and vaccination of tuberculosis MOHSEN TAFAGHODI, FARZAD KHADEMI, FARIDEH SHIEHZADEH AND ZOHREH FIROZI9. Nanotechnology-based approaches for tuberculosis treatmentMOHAMAD MOSA MUBARAK AND ZAHOOR AHMAD10. Dendrimer-based drug delivery systems for tuberculosis treatmentRAHUL SHUKLA, AAKRITI SETHI, MAYANK HANDA, MRADUL MOHAN, PRASHANT KESHARWANI AND PUSHPENDRA K. TRIPATHI11. Polymeric micelle-based drug delivery systems for tuberculosis treatmentBAPI GORAIN, HIRA CHOUDHURY, SREENIVAS PATRO AND PRASHANT KESHARWANI12. Nanostructured lipid carrier-based drug delivery systems for tuberculosis treatmentSIMONE PINTO CARNEIRO AND ORLANDO DAVID HENRIQUE DOS SANTOS13. DNA markers and nano-biosensing approaches for tuberculosis diagnosisAMAL RABTI, AMAL RAOUAFI AND NOUREDDINE RAOUAFI14. Recent advancement and future perspective for the treatment of multidrug-resistant tuberculosis Noorsuzana Mohd Shariff15. Nanotechnology approach in conquering anti-TB resistanceB.D. NOVITA
- Edition: 1
- Published: June 11, 2020
- Language: English
PK
Prashant Kesharwani
Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 350 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, most prestigious “SERB-Ramanujan Fellowship Award”. He actively participates in outreach and scientific dissemination for the service of the wider community. His Number of citations is = 26779; h-index = 85; i-10 index = 370 (According to google scholar on March 2025). He has more than 30 international publications published in very high impact factor journals (Progress in Polymer Sciences IF 32.063, Molecular Sciences IF 41.444, Progress in Material Sciences IF 48.580, Advanced Materials IF 29.4, Drug Resistance Update IF 22.841 and Material Todays IF 32.072). He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community.
Affiliations and expertise
Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, IndiaRead Nanotechnology Based Approaches for Tuberculosis Treatment on ScienceDirect